D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

INZY holding history

Inozyme Pharma, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INZY overview All 13F holders of INZY Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2024

Holdings of INZY by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−53,381−100.0%	Sold out	Holders
Q1 2025	53,381	$48.6K	<0.1%	+35,568+199.7%	Added	Holders
Q4 2024	17,813	$49.3K	<0.1%	+17,813	New	Holders